MedPath

A Community-based Advance Care Planning Programme for Patients With Advanced Disease

Not Applicable
Completed
Conditions
Chronic Disease
Interventions
Behavioral: Advance care planning programme
Registration Number
NCT02068651
Lead Sponsor
Food and Health Bureau, Hong Kong
Brief Summary

Advance care planning has been recommended as an integral part of care for patients with life-limiting disease, but relevant development in Hong Kong is still in its infancy. This proposed study attempts to address this service gap by promoting advance care planning to patients with advanced disease. It is hypothesized that the proportion of patients whose end-of-life care preferences were known in the experimental group will be significantly higher than that in the control group.

Detailed Description

This study aims to evaluate the impacts of a community-based advance care planning programme on end-of-life care of patients with advanced disease. A mixed-method approach, including a randomized controlled trial and qualitative interviews, will be used. Participants in the experimental group will received a structured advance care planning programme delivered by a trained facilitator. It includes an educational component, reflection and a family meeting.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
239
Inclusion Criteria
  • aged 18 or above
  • meet one of the three triggers for supportive /palliative care as suggested in the Gold Standards Framework
  • living at home
  • being communicable
Exclusion Criteria
  • mentally incompetent
  • cannot nominate a family carer
  • have already signed an advance directive
  • have been referred to palliative care service

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Advance care planning programmeAdvance care planning programmeParticipants in the experimental group will receive a structured advance care planning programme, namely Let Me Talk, delivered by a trained nurse facilitator. The programme will be conducted on individual basis through three one-hour home visits, once weekly. Family carers of the participants will be invited to all sessions.
Primary Outcome Measures
NameTimeMethod
End-of-life care preferences6 months

In this study, end-of-life care preferences include goal for end-of-life care and decisions over the use of life-sustaining treatments relevant to individual's anticipated health changes. So, whether the patients' end-of-life care preferences is known at different timepoints will be determined based on (1) the congruence between patients' end-of-life care preferences and family carers' predicted end-of-life care preferences for patients; and (2) whether patients' end-of-life preferences are documented in their medical record.

Secondary Outcome Measures
NameTimeMethod
Level of certainty about future care6 months

The SURE test (Legare, Kearing, Clay, Gagnon, D'Amours, Rousseau \& O'Connor, 2010) will be used to measure the patient's level of decisional conflict in making decisions related to future care. Patients will be asked to rate their certainty in their future care on four items by using a dichotomous response format: yes or no. Good construct validity and reliability were demonstrated. It has previously been translated into Chinese and tested among local older people .

Health care utilization6 months

Patient's medical records will be retrieved retrospectively six months after their enrolment to review their health care utilization over the study period, including the number of visits to the emergency department, unplanned admission, length of hospital stay, as well as investigation, procedures and treatment received.

Trial Locations

Locations (1)

Haven of Hope Hospital

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath